By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

EV Resources has confirmed high-grade antimony samples from first assays at its newest potential near-term production asset ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the ...

Acrivon Therapeutics, Inc. (NASDAQ: ACRV), a clinical stage biopharmaceutical company with a market capitalization of $184 million and an impressive 60% stock return over the past year, announced that ...

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...

InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.

Center of Clinical Laboratory Medicine, Zhongda Hospital, Medical School of Southeast University, Nanjing 210009, Jiangsu, China Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, ...

Merck KGaA (Merck) and Opentrons Labworks have announced a partnership to automate assay kits on a ‘custom’ Opentrons Flex workstation. The multi-year collaboration will see scientists and engineers ...

Start your journey with GitHub Building great software is a big challenge, and development teams rely on the software development lifecycle (SDLC) to help them succeed. SDLC stands for software ...

The problem of economic development in the Global South remains as important as ever. For centuries thinkers have tried to explain why some countries grow rich while others remain poor, with varied ...

Together, the custom workstation and automation-enabled assays will deliver increased ... quality of products they offer for pharmaceutical development and manufacturing, and we’re excited ...